GlassScriptPhysician profile
Jacob J Moore
NPI 1144249277
$1,507.21
in general payments reported to CMS, 2019-2025
9 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $110 · 2021: $156 · 2022: $331 · 2023: $165 · 2024: $168 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $377.28 | 2021-2024 | Total30, Centurion |
| Johnson & Johnson Surgical Vision, INC. | $349.98 | 2019-2023 | Veritas Vision System |
| Abbvie INC. | $222.83 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.00 | 2019 | |
| Bausch & Lomb Americas INC. | $122.16 | 2025 | Xiidra, Miebo |
| Allergan, INC. | $121.00 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $105.38 | 2019 | |
| Harrow Eye, LLC | $29.89 | 2025 | Triesence |
| Aerie Pharmaceuticals, INC. | $28.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.